Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Medipharm Labs Corp (LABS.TO)

Medipharm Labs Corp (LABS.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 73,855
  • Shares Outstanding, K 263,769
  • Annual Sales, $ 36,012 K
  • Annual Income, $ -66,353 K
  • 60-Month Beta 0.22
  • Price/Sales 2.43
  • Price/Cash Flow N/A
  • Price/Book 0.67
Trade LABS.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.44
  • Most Recent Earnings -0.05 on N/A
  • Next Earnings Date 08/12/21
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.01
  • Number of Estimates 2
  • High Estimate -0.01
  • Low Estimate -0.02
  • Prior Year -0.11
  • Growth Rate Est. (year over year) +90.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2700 +1.85%
on 09/28/21
0.3450 -20.29%
on 08/31/21
-0.0550 (-16.67%)
since 08/27/21
3-Month
0.2700 +1.85%
on 09/28/21
0.4750 -42.11%
on 07/14/21
-0.1800 (-39.56%)
since 06/28/21
52-Week
0.2700 +1.85%
on 09/28/21
1.1000 -75.00%
on 10/13/20
-0.6050 (-68.75%)
since 09/28/20

Most Recent Stories

More News
Stocks in play: MediPharm Labs Corp.

Announced that the Company’s research partner McMaster University has received a no objection letter ...

LABS.TO : 0.2750 (-1.79%)
Stocks in play: MediPharm Labs Corp.

Announced its wholly owned subsidiary MediPharm Labs Australia Pty Ltd has been awarded $330,000 as ...

LABS.TO : 0.2750 (-1.79%)
Another Near Billion-Dollar Cannabis Acquisition Signals More Hyper Valuations to Come

/PRNewswire/ --   -  As part of its recent cannabis M&A spree,  (NYSE: HEXO) (TSX: HEXO) spent nearly another billion dollars, acquiring  privately-owned licensed cannabis producer Redecan for...

PRXTF : 0.2128 (-11.00%)
PULL.CN : 0.270 (-10.00%)
LABS.TO : 0.2750 (-1.79%)
MEDIF : 0.2176 (-2.73%)
VLNCF : 1.9800 (-2.47%)
VLNS.TO : 2.50 (-2.72%)
NEPT : 0.6207 (-6.59%)
NEPT.TO : 0.78 (-7.14%)
HEXO : 1.93 (-5.39%)
HEXO.TO : 2.44 (-5.43%)
Another Near Billion-Dollar Cannabis Acquisition Signals More Hyper Valuations to Come

VANCOUVER – USA News Group – As part of its recent cannabis M&A spree, HEXO Corp. (NYSE:HEXO) ...

PRXTF : 0.2128 (-11.00%)
LABS.TO : 0.2750 (-1.79%)
MEDIF : 0.2176 (-2.73%)
VLNCF : 1.9800 (-2.47%)
VLNS.TO : 2.50 (-2.72%)
NEPT : 0.6207 (-6.59%)
NEPT.TO : 0.78 (-7.14%)
HEXO : 1.93 (-5.39%)
HEXO.TO : 2.44 (-5.43%)
PULL.CN : 0.270 (-10.00%)
Another Near Billion-Dollar Cannabis Acquisition Signals More Hyper Valuations to Come

VANCOUVER – Fly On Wall Street – As part of its recent cannabis M&A spree, HEXO Corp. ...

PRXTF : 0.2128 (-11.00%)
LABS.TO : 0.2750 (-1.79%)
MEDIF : 0.2176 (-2.73%)
VLNCF : 1.9800 (-2.47%)
VLNS.TO : 2.50 (-2.72%)
NEPT : 0.6207 (-6.59%)
NEPT.TO : 0.78 (-7.14%)
HEXO : 1.93 (-5.39%)
HEXO.TO : 2.44 (-5.43%)
PULL.CN : 0.270 (-10.00%)
Stocks in play: MediPharm Labs Corp.

Will release first-quarter financial results for the three month period ended March 31, 2021 before ...

LABS.TO : 0.2750 (-1.79%)
Number Of Cannabis Patents Granted In Europe & UK Growing At A Quick Pace

, /PRNewswire/ -- The worldwide explosion of the recreational and medical cannabis markets, and submarkets, appears that it will continue for years to come. New industries have been born, new mega-companies...

OILFF : 0.1808 (+1.06%)
OILS.CN : 0.235 (+2.17%)
CGC : 14.21 (-3.40%)
WEED.TO : 18.05 (-2.90%)
GWPH : 218.96 (-0.15%)
MEDIF : 0.2176 (-2.73%)
LABS.TO : 0.2750 (-1.79%)
VLNCF : 1.9800 (-2.47%)
VLNS.TO : 2.50 (-2.72%)
Adjupharm Signs Supply Agreement with MediPharm Labs, Paving Way for IM Cannabis-Branded Extracts Launch in German Market

TORONTO, ON and BAD OLDESLOE, GERMANY and GLIL YAM, ISRAEL / ACCESSWIRE / April 13, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical...

IMCC.CN : 4.470 (+0.45%)
IMCC : 3.46 (-1.42%)
LABS.TO : 0.2750 (-1.79%)
MEDIF : 0.2176 (-2.73%)
Stocks in play: MediPharm Labs Corp.

Today announced it has exported its first shipment of cannabis oil products, approved by the Australian ...

LABS.TO : 0.2750 (-1.79%)
Canada Jobs Due for Next Week

Monday U.S. Economic Lookahead Markit Services Purchasing Managers Index (final) (March) ...

ORMP : 22.67 (-4.83%)
SEAC : 1.0700 (-0.93%)
PAYX : 106.73 (-1.88%)
LNN : 153.52 (-0.39%)
GBX : 43.81 (-0.79%)
SGH : 46.62 (-4.70%)
RPM : 78.65 (-0.79%)
LW : 61.29 (-0.39%)
SMPL : 34.44 (-1.96%)
STZ : 209.96 (-0.81%)
LEVI : 25.48 (-1.39%)
C : 71.37 (-1.23%)
LABS.TO : 0.2750 (-1.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 0.3033
2nd Resistance Point 0.2967
1st Resistance Point 0.2883
Last Price 0.2750
1st Support Level 0.2733
2nd Support Level 0.2667
3rd Support Level 0.2583

See More

52-Week High 1.1000
Fibonacci 61.8% 0.7829
Fibonacci 50% 0.6850
Fibonacci 38.2% 0.5871
Last Price 0.2750
52-Week Low 0.2700

See More

Business Summary

MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream, 2:1 CBD:THC,...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar